“…There is a lack of centralized authentication systems that provide taxon identification with high-resolution power. The predominance of species-specific PCR assays (Noh et al, 2021; Sharma and Shrivastava, 2016) DNA barcoding(Bansal et al, 2018; Seethapathy et al, 2015; Thakur et al, 2019; Vassou et al, 2016), and metabarcoding (Raclariu et al, 2017; Raclariu et al, 2017; Raclariu et al, 2018b; Seethapathy et al, 2019) based molecular authentication of medicinal plants has recently undergone a revolution, mostly because of DNA’s accessibility, consistency, and independence from tissue characteristics, age, harvesting techniques, and storage conditions. Chinese Pharmacopoeia, United States Pharmacopeia, British Pharmacopoeia, Japanese Pharmacopoeia, and Hong Kong Chinese Materia Medica are advocating DNA-based authentication around the globe (Wu and Shaw, 2022).…”